查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球过敏治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测
市场调查报告书
商品编码
1377827

全球过敏治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测

Global Allergy Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

全球过敏治疗市场需求预计将从 2022 年的 229 亿美元增加到 2030 年的近 405.4 亿美元，2023-2030 年研究期间CAGR为 7.4%。

过敏治疗，也称为过敏免疫疗法或过敏注射，是一种旨在帮助过敏个体建立对特定过敏原（引发过敏反应的物质）的耐受性的医学治疗方法。过敏是免疫系统对花粉、尘螨、宠物皮屑或某些食物等通常无害物质的反应。这可能会导致打喷嚏、搔痒、充血、荨麻疹，在某些情况下甚至会导致严重的过敏反应。

市场动态：

全球过敏症盛行率不断上升，包括过敏性鼻炎、气喘和食物过敏等，对市场成长有正面影响。生活方式的改变、城市化和接触环境过敏原促成了这一趋势，促使个人寻求有效的过敏管理解决方案。治疗方式的进步，包括舌下免疫疗法 (SLIT) 片剂等创新选择，为患者提供了比传统过敏注射更方便、更个性化的替代方案。此外，患者对过敏的认识和教育的提高，加上医疗基础设施的改善和专业护理的获得，导致对过敏治疗的需求更大。过敏测试技术的进步、政府促进有效过敏管理的倡议以及对职业过敏的认识进一步提振了市场。食物过敏、全球旅行以及对昆虫毒液过敏治疗的需求的增加也促进了市场的成长。製药公司和学术机构之间正在进行的研究、临床试验以及合作正在推动新的和改进的过敏疗法的开发。随着过敏继续影响公共健康和福祉，市场预计将扩大，为个人提供更有效和个人化的过敏管理选择。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球过敏治疗市场的每个细分市场进行了包容性评估。过敏治疗产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲过敏治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。过敏治疗市场的主要参与者包括 Allergopharma、丹纳赫、艾伯维公司、过敏治疗公司、赛诺菲公司、辉瑞公司、梯瓦製药工业有限公司、葛兰素史克公司、罗氏公司和默克公司., Inc. 本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：过敏治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按治疗类型进行的市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球过敏治疗市场分析：依治疗类型

  • 按治疗类型概述
  • 历史和预测数据
  • 依治疗类型分析
  • 抗过敏药物（抗组织胺、皮质类固醇、其他药物）
  • 免疫治疗（皮下免疫治疗（SCIT）、舌下免疫治疗（SLIT））

第 6 章：全球过敏治疗市场分析：按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 眼睛过敏
  • 气喘
  • 皮肤过敏
  • 食物过敏
  • 鼻炎
  • 其他过敏类型

第 7 章：全球过敏治疗市场分析：按给药途径

  • 依给药途径概述
  • 历史和预测数据
  • 依给药途径分析
  • 口服
  • 吸入器
  • 鼻内
  • 其他给药途径

第 8 章：全球过敏治疗市场分析：按分销管道

  • 按配销通路分類的概览
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 零售药局
  • 其他分销管道

第 9 章：全球过敏治疗市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：过敏治疗公司的竞争格局

  • 过敏治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Allergopharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Danaher
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AbbVie Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Allergy Therapeutics plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sanofi SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pfizer Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Teva Pharmaceutical Industries Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GlaxoSmithKline plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck & Co. Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112112190

The global demand for Allergy Therapeutics Market is presumed to reach the market size of nearly USD 40.54 BN by 2030 from USD 22.9 BN in 2022 with a CAGR of 7.4% under the study period 2023 - 2030.

Allergy therapeutics, also known as allergy immunotherapy or allergy shots, are medical treatments designed to help individuals with allergies build a tolerance to specific allergens (substances that trigger allergic reactions). Allergy is an immune system response to normally harmless substances like pollen, dust mites, pet dander, or certain foods. This can lead to sneezing, itching, congestion, hives, or even severe allergic reactions in some cases.

MARKET DYNAMICS:

The increasing prevalence of allergies worldwide, including conditions like allergic rhinitis, asthma, and food allergies, is positively affecting the market growth. Lifestyle changes, urbanization, and exposure to environmental allergens contribute to this trend, prompting individuals to seek effective allergy management solutions. Advancements in treatment modalities, including innovative options like sublingual immunotherapy (SLIT) tablets, offer patients more convenient and personalized alternatives to traditional allergy shots. Additionally, heightened patient awareness and education about allergies, coupled with improved healthcare infrastructure and access to specialized care, have led to greater demand for allergy therapeutics. Technological advancements in allergy testing, government initiatives promoting effective allergy management, and the recognition of occupational allergies further bolster the market. The rise in food allergies, global travel, and the need for insect venom allergy treatments also contribute to market growth. Ongoing research, clinical trials, and collaborations between pharmaceutical companies and academic institutions are driving the development of new and improved allergy therapeutics. As allergies continue to impact public health and well-being, the market is expected to expand, providing individuals with more effective and personalized options for allergy management.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of allergy therapeutics. The growth and trends of allergy therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the allergy therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT))

By Type

  • Eye Allergy
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Rhinitis
  • Other Allergy Types

By Route Of Administration

  • Oral
  • Inhalers
  • Intranasal
  • Other Routes Of Administration

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Allergy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Allergy Therapeutics market include Allergopharma, Danaher, AbbVie Inc., Allergy Therapeutics plc, Sanofi SA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Merck & Co., Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ALLERGY THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Treatment Type
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

  • 5.1 Overview by Treatment Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Treatment Type
  • 5.4 Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Historic and Forecast Sales by Regions
  • 5.5 Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Historic and Forecast Sales by Regions

6 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Eye Allergy Historic and Forecast Sales by Regions
  • 6.5 Asthma Historic and Forecast Sales by Regions
  • 6.6 Skin Allergy Historic and Forecast Sales by Regions
  • 6.7 Food Allergies Historic and Forecast Sales by Regions
  • 6.8 Rhinitis Historic and Forecast Sales by Regions
  • 6.9 Other Allergy Types Historic and Forecast Sales by Regions

7 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route Of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route Of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Inhalers Historic and Forecast Sales by Regions
  • 7.6 Intranasal Historic and Forecast Sales by Regions
  • 7.7 Other Routes Of Administration Historic and Forecast Sales by Regions

8 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Other Distribution Channels Historic and Forecast Sales by Regions

9 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ALLERGY THERAPEUTICS COMPANIES

  • 10.1. Allergy Therapeutics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF ALLERGY THERAPEUTICS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Allergopharma
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Danaher
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. AbbVie Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Allergy Therapeutics plc
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Sanofi SA
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Pfizer Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Teva Pharmaceutical Industries Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. GlaxoSmithKline plc
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. F. Hoffmann-La Roche Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Merck & Co. Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Treatment Type (USD MN)
  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Market Sales by Geography (USD MN)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Market Sales by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Eye Allergy Market Sales by Geography (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Skin Allergy Market Sales by Geography (USD MN)
  • Food Allergies Market Sales by Geography (USD MN)
  • Rhinitis Market Sales by Geography (USD MN)
  • Other Allergy Types Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Inhalers Market Sales by Geography (USD MN)
  • Intranasal Market Sales by Geography (USD MN)
  • Other Routes Of Administration Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Other Distribution Channels Market Sales by Geography (USD MN)
  • Global Allergy Therapeutics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Allergy Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Allergy Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Market Sales by Geography (USD MN)
  • Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Eye Allergy Market Sales by Geography (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Skin Allergy Market Sales by Geography (USD MN)
  • Food Allergies Market Sales by Geography (USD MN)
  • Rhinitis Market Sales by Geography (USD MN)
  • Other Allergy Types Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Inhalers Market Sales by Geography (USD MN)
  • Intranasal Market Sales by Geography (USD MN)
  • Other Routes Of Administration Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Other Distribution Channels Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.